Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate dosing for bleeding control during lumbar spinal fusion surgery
IRCT20200825048515N15Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of magnesium sulfate in intraoperative bleeding (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Bleeding volume, Heart rate and 4 more. Started Dec 2020; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
intraoperative bleeding
Beyond the preview
Go deeper on IRCT20200825048515N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N15.